Article Details

Analysis of regulatory policy for approval of digital therapeutics | China Business Law

Retrieved on: 2022-05-06 09:26:54

Tags for this article:

Click the tags to see associated articles and topics

Analysis of regulatory policy for approval of digital therapeutics | China Business Law. View article details on hiswai:

Excerpt

AI medical software refers to standalone software based on medical device data and AI technology to achieve its medical purposes, ...

Article found on: law.asia

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up